Paper6831367
Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and Stage I disease.
Christopherson WM and 2 others. Cancer, 1983. Cited by 149 papers, by iCite.
Cite this record
ConductScience Library. Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and Stage I disease. Papers, record 6831367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6831367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Uterine Neoplasms | Major topic |
| Adenocarcinoma | |
| Age Factors | |
| Carcinoma, Papillary | |
| Carcinoma, Squamous Cell | |
| Female | |
| Humans | |
| Kentucky | |
| Middle Aged | |
| Myometrium | |
| Neoplasm Staging | |
| Prognosis | |
| Racial Groups | |
| Registries |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 1-CN-45059 | NCI NIH HHS | United States | N01CN045059 | PubMed and NIH |
Source NIH RePORTER
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 149 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37754489 | An Overview of Endometrial Cancer with Novel Therapeutic Strategies. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37754489 | PubMed |
| 20542546 | MicroRNA signatures differentiate uterine cancer tumor subtypes. | Gynecol Oncol | 2010 | https://conductscience.org/library/papers/20542546 | PubMed |
| 10027332 | Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer. | Br J Cancer | 1999 | https://conductscience.org/library/papers/10027332 | PubMed |
| 9577367 | Endometrial carcinoma: immunohistochemically detected proliferation index is a prognosticator of long-term outcome. | J Clin Pathol | 1998 | https://conductscience.org/library/papers/9577367 | PubMed |
| 9038731 | Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma. | J Clin Pathol | 1996 | https://conductscience.org/library/papers/9038731 | PubMed |
| 8664123 | Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8664123 | PubMed |
| 3055700 | Sex steroid receptors in endometrial cancer. | Yale J Biol Med | 1988 | https://conductscience.org/library/papers/3055700 | PubMed |
| 2470714 | Proliferative cell index in endometrial adenocarcinoma of different nuclear grades. | Jpn J Cancer Res | 1989 | https://conductscience.org/library/papers/2470714 | PubMed |
| 2202159 | Pathophysiology and management of endometrial hyperplasia and carcinoma. | West J Med | 1990 | https://conductscience.org/library/papers/2202159 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6831367
GET https://conductscience.org/api/papers/v1/6831367/authors